Poland· PL-100502367

Zegalogue

A dasiglucagon product containing dasiglucagonum, registered in Poland by Zealand Pharma A/S. The same ATC class is registered in 8 of our 19 countries.

ATC H04AA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedZegalogueATCH04AA02REGISTER NO.PL-100502367PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Dasiglucagon is registered in 8 of 19 countries.

Countries holding a registration under ATC H04AA02 (dasiglucagon), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose

Dasiglucagon · ATC H04AA02

8 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Dasiglucagonum
Manufacturer
Zealand Pharma A/S
Country
Poland (PL)
ATC code
H04AA02
ATC class
Dasiglucagon
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dasiglucagon in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dasiglucagon products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/26f6e8c9-4b8f-4979-a84d-689a730b1e6a
GET /v1/drugs/26f6e8c9-4b8f-4979-a84d-689a730b1e6a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań w ampułko-strzykawce",
  "source": "urpl",
  "strength": "0,6 mg/0,6 ml",
  "packaging": "Rp ¦ EU/1/24/1829/003 ¦ 157489\n1 amp.-strzyk. 0,6 ml\nRp ¦ EU/1/24/1829/004 ¦ 157490\n2 amp.-strzyk. 0,6 ml",
  "substance": "Dasiglucagonum 0.6 mg/0.6 ml",
  "common_name": "Dasiglucagonum",
  "pl_product_id": "100502367",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": "2026-02-23"
}

See everything about dasiglucagon.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.